| 研究所： | | | --- | --- | | 证券分析师： | 李永磊 S0350521080004 | | | liyl03@ghzq.com.cn | | 证券分析师： | 董伯骏 S0350521080009 | | | dongbj@ghzq.com.cn | | 证券分析师： | 李娟廷 S0350524090007 | | | lijt03@ghzq.com.cn | | [Table_Title] 业绩大增，磷矿产能扩张看好成长性 Q2 | | --- | | ——川恒股份（002895）公司动态研究 | 投资要点: 磷化工产品收入提升，2025 年上半年业绩同比增长 2025 年上半年公司实现营业收入 33.60 亿元，同比增长 35.28%； 实现归属于上市公司股东的净利润 5.36 亿元，同比增长 51.54%； 加权平均净资产收益率为 8.26%，同比增加 2.19 个百分点。销售毛 利率 31.16%，同比减少 2.06 个百分点；销售净利率 16.63%，同比 增加 2.73 个百分点。其中，公司 2025Q2 实现营收 18.67 亿元，同 比+29.63%，环比+25.0 ...

证券代码：002895 证券简称：川恒股份 公告编号：2025-114 贵州川恒化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 贵州川恒化工股份有限公司（以下简称公司）于 2025 年 2 月 25 日召开第四 届董事会第六次会议，2025 年 3 月 14 日召开 2025 年第一次临时股东大会，审 议通过了《回购公司股份的议案》，同意公司以集中竞价交易方式回购部分公司 股份用于注销并减少注册资本，回购金额不低于人民币 4,000 万元（含）且不超 过人民币 8,000 万元（含），回购价格不超过 24.33 元/股（未超过董事会通过回 购决议前 30 个交易日均价的 150%），回购资金为自有资金，实施期限为股东大 会审议通过回购方案之日起 12 个月内。具体回购数量、回购资金总额以回购期 限届满时实际回购股份使用的资金总额、回购股份数量为准。具体内容详见公司 于 2025 年 2 月 26 日及 3 月 15 日在信息披露媒体披露的《回购公司股份方案的 公告》（公告编号：2025-011）及《回购报告书》（公告编号：2025-018）。 ...

格隆汇9月3日丨川恒股份(002895.SZ)公布，截至2025年8月31日，公司通过深圳证券交易所交易系统以 集中竞价方式回购股份数量为1,760,300股，占公司当前总股本的0.29%，最高成交价为23.90元/股，最 低成交价为22.00元/股，支付的总金额为40,139,399.00元（不含交易费用）。 ...

证券代码：002895 证券简称：川恒股份 公告编号：2025-114 贵州川恒化工股份有限公司 回购公司股份进展情况的公告（六） 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 贵州川恒化工股份有限公司（以下简称公司）于 2025 年 2 月 25 日召开第四 届董事会第六次会议，2025 年 3 月 14 日召开 2025 年第一次临时股东大会，审 议通过了《回购公司股份的议案》，同意公司以集中竞价交易方式回购部分公司 股份用于注销并减少注册资本，回购金额不低于人民币 4,000 万元（含）且不超 过人民币 8,000 万元（含），回购价格不超过 24.33 元/股（未超过董事会通过回 购决议前 30 个交易日均价的 150%），回购资金为自有资金，实施期限为股东大 会审议通过回购方案之日起 12 个月内。具体回购数量、回购资金总额以回购期 限届满时实际回购股份使用的资金总额、回购股份数量为准。具体内容详见公司 于 2025 年 2 月 26 日及 3 月 15 日在信息披露媒体披露的《回购公司股份方案的 公告》（公告编号：2025-011）及《回购报告书 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a rapid growth in performance for the first half of 2025, with total revenue reaching 3.36 billion yuan, a year-on-year increase of 35.28%, and a net profit attributable to shareholders of 536 million yuan, up 51.54% year-on-year [5] - The company is continuously deepening its industrial chain layout, focusing on the integration of phosphate resources and capacity construction [6] - The company has a strong competitive advantage due to its dual-driven strategy of resource and technology, which helps in building a long-term competitive barrier [7] Financial Performance - In the first half of 2025, the company achieved total revenue of 3.36 billion yuan, with a year-on-year growth of 35.28% and a net profit of 536 million yuan, reflecting a year-on-year increase of 51.54% [5] - The revenue from the phosphate chemical segment grew rapidly, with key products such as feed-grade dicalcium phosphate and monoammonium phosphate showing revenue increases of 33.22% and 38.91% respectively [5] - The company’s gross profit margin for feed-grade dicalcium phosphate and monoammonium phosphate improved, with margins of 32.60% and 44.57% respectively [5] Industry Positioning - The company is actively expanding its overseas market presence, with international sales revenue reaching 1.066 billion yuan, a year-on-year increase of 35.05%, accounting for 31.73% of total revenue [5] - The company is enhancing its integrated industrial chain centered around phosphate rock resources, with a current annual mining capacity of approximately 3.2 million tons [6] - The company is also increasing its production capacity for lithium iron phosphate, responding to the growing demand in the new energy materials market [5][8] Future Outlook - The company is expected to achieve net profits of 1.229 billion yuan, 1.444 billion yuan, and 1.853 billion yuan for the years 2025 to 2027, with corresponding P/E ratios of 13, 11, and 9 times [9]

Core Insights - Guizhou listed companies have shown significant growth in both revenue and net profit, with 25 companies reporting profits and 19 companies achieving year-on-year revenue growth in the first half of 2025 [1][2][3] Revenue Performance - In the first half of 2025, Guizhou listed companies achieved a total revenue of 172.85 billion yuan, representing a year-on-year increase of 6.03% and a 52.29% increase compared to the same period in 2021 [2] - The revenue growth rate of Guizhou listed companies is ranked 4th nationally and 3rd in the western region, surpassing the GDP growth rate of Guizhou by 0.73 percentage points [2] - Among these companies, 18 have revenues exceeding 1 billion yuan, and 6 have revenues exceeding 5 billion yuan, with Kweichow Moutai leading at 89.39 billion yuan [2] Profitability - Guizhou listed companies reported a total net profit of 50.26 billion yuan in the first half of 2025, ranking 9th nationally and 2nd in the western region, with a year-on-year increase of 5.37% and a 60.45% increase compared to 2021 [3] - 71.43% of the companies reported profits, with Kweichow Moutai again leading at 45.40 billion yuan [3] Innovation and R&D - A total of 33 Guizhou listed companies disclosed R&D expenditures, totaling 2.52 billion yuan, a slight increase of 0.04% year-on-year and a 70.18% increase compared to 2021 [4] - 6 companies reported R&D expenditures exceeding 100 million yuan, with Zhongwei Co. leading at 545 million yuan [4] International Business - 13 companies reported overseas business income totaling 18.29 billion yuan, reflecting an 18.66% year-on-year increase, with Zhongwei Co. achieving 10.78 billion yuan in overseas revenue [5] Investor Returns - In the first half of 2025, 7 Guizhou listed companies announced interim dividend plans, with a total dividend amount of 591 million yuan, nearly quadrupling from the previous year [7] - 8 companies engaged in share buybacks, investing a total of 7.14 billion yuan, ranking 6th nationally [7]

Group 1 - The core viewpoint of the article highlights the significant changes in stock holdings by securities firms during the second quarter, with a focus on industries such as basic chemicals, machinery, automotive, and pharmaceuticals [1] - Securities firms collectively increased their positions in 63 stocks during the second quarter, with notable additions including Zhongke Titanium White, New Mileage, Jiangzhong Pharmaceutical, and Yuntianhua [1] - Several companies, including Chuanheng Co., Furan Energy, Ruida Futures, and Zhejiang Huaye, received attention from at least three securities firms, indicating strong interest [1] Group 2 - In terms of holding scale, data from Choice shows that Jiangsu Bank, Yong'an Futures, CITIC Securities, and Sinopec have the highest total shareholdings among securities firms [1] - As of the closing price on June 30, 2025, Jiangsu Bank leads with a holding market value of 11.026 billion yuan, followed by CITIC Securities and Yong'an Futures with 9.208 billion yuan and 6.507 billion yuan respectively [1] - Other companies such as Muyuan Foods, Cangge Mining, Sinopec, and Guangqi Technology also have significant market values in securities holdings [1]

证券代码：002895 证券简称：川恒股份 公告编号：2025-113 贵州川恒化工股份有限公司 实施 2025 年半年度利润分配后调整回购股份价格上限的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、回购股份方案概述 贵州川恒化工股份有限公司（以下简称"公司"）于 2025 年 2 月 25 日召开第 四届董事会第六次会议，2025 年 3 月 14 日召开 2025 年第一次临时股东大会，审 议通过了《回购公司股份的议案》，同意公司以集中竞价交易方式回购部分公司股 份用于注销并减少注册资本，回购金额不低于人民币 4,000 万元（含）且不超过人 民币 8,000 万元（含），回购价格不超过 24.33 元/股（未超过董事会通过回购决议 前 30 个交易日均价的 150%），回购资金为自有资金，实施期限为股东大会审议通 过回购方案之日起 12 个月内。具体回购数量、回购资金总额以回购期限届满时实 际回购股份使用的资金总额、回购股份数量为准。具体内容详见公司于 2025 年 2 月 26 日及 3 月 15 日在信息披露媒体披露的《回购公司股份方案的 ...

证券代码：002895 证券简称：川恒股份 公告编号：2025-112 贵州川恒化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 二、本次实施的利润分配方案 公司 2025 年半年度利润分配方案为：以公司现有总股本剔除已回购股份 金（含税；扣税后，QFII、RQFII 以及持有首发前限售股的个人和证券投资基金 每 10 股派 2.70 元；持有首发后限售股、股权激励限售股及无限售流通股的个人 股息红利税实行差别化税率征收，本公司暂不扣缴个人所得税，待个人转让股票 时，根据其持股期限计算应纳税额【注】；持有首发后限售股、股权激励限售股 及无限售流通股的证券投资基金所涉红利税，对香港投资者持有基金份额部分按 【注：根据先进先出的原则，以投资者证券账户为单位计算持股期限，持股 三、分红派息日期 本次利润分配的股权登记日为：2025 年 9 月 4 日，除权除息日为：2025 年 四、分红派息对象 截至 2025 年 9 月 4 日下午深圳证券交易所收市后，在中国结算深圳分公司 登记在册的全体股东。 以公司现有总股本 607,666,683 ...

Core Insights - The report emphasizes that the chemical industry is entering a new phase of capital expenditure, with a focus on the rebalancing of supply and demand following the release of production capacity during the 14th Five-Year Plan period [2][6] - The report indicates that the bottom of the cycle is becoming clearer, with potential price increases for chemical products driven by demand recovery and supply stability in the second half of the year [2][6] Industry Overview - The current cycle has reached its tail end, with a total of 12 quarters of decline since Q3 2022, following a 7-quarter expansion from Q4 2020 to Q2 2022 [10][12] - The report outlines that the chemical industry has experienced three significant price fluctuation cycles since 2010, with the latest cycle characterized by a demand-driven recovery followed by a supply-side pressure [8][10] Investment Recommendations - The report suggests focusing on sectors with relatively low valuations, such as sucralose (recommended: Jinhe Industrial), pesticides (recommended: Yangnong Chemical, Runfeng Shares), and MDI (recommended: Wanhua Chemical) [3][4] - It highlights the importance of domestic demand in countering tariff impacts, recommending companies in refrigerants and fertilizers [3][4] - The report identifies investment opportunities in sectors with upcoming capacity releases, such as organic silicon (recommended: Xin'an Chemical) and spandex [3][4] Price and Profitability Trends - The report notes that many sub-industry product prices remain at historical lows, with specific prices for spandex, PA6, and other fibers at 0%, 4%, and 5% of historical levels respectively [28] - It mentions that the chemical industry has seen a slight recovery in profitability in Q1 2025, although the overall performance remains under pressure [27][25] Supply and Demand Dynamics - The report indicates that the global chemical capital expenditure is on a downward trend, with domestic companies experiencing a slowdown in investment while still facing significant pressure to convert projects into fixed assets [22][32] - It also states that both domestic and international markets are entering a replenishment phase in 2025, which may influence inventory levels and pricing strategies [35][36]